Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research

NA Turner, BK Sharma-Kuinkel… - Nature Reviews …, 2019 - nature.com
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successful modern
pathogens. The same organism that lives as a commensal and is transmitted in both health …

Methicillin-resistant Staphylococcus aureus

AS Lee, H De Lencastre, J Garau… - Nature reviews Disease …, 2018 - nature.com
Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged,
disseminated globally and become a leading cause of bacterial infections in both health …

European Heart rhythm association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections …

C Blomström-Lundqvist, V Traykov… - European Journal of …, 2020 - academic.oup.com
Pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy
devices are potentially life-saving treatments for a number of cardiac conditions, but are not …

Considerations and caveats in combating ESKAPE pathogens against nosocomial infections

YX Ma, CY Wang, YY Li, J Li, QQ Wan… - Advanced …, 2020 - Wiley Online Library
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA …

SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson… - Jama, 2020 - jamanetwork.com
Importance Methicillin-resistantStaphylococcus aureus (MRSA) bacteremia is associated
with mortality of more than 20%. Combining standard therapy with a β-lactam antibiotic has …

[PDF][PDF] Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK

NM Brown, AL Goodman, C Horner… - JAC-antimicrobial …, 2021 - academic.oup.com
These evidence-based guidelines are an updated version of those issued in 2008. They
have been produced following a review of the published literature (2007–18) pertaining to …

The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe

SYC Tong, J Mora, AC Bowen… - Clinical Infectious …, 2022 - academic.oup.com
Staphylococcus aureus bloodstream (SAB) infection is a common and severe infectious
disease, with a 90-day mortality of 15%–30%. Despite this,< 3000 people have been …

Native-valve infective endocarditis

HF Chambers, AS Bayer - New England Journal of Medicine, 2020 - Mass Medical Soc
Key Clinical Points Native-Valve Infective Endocarditis The modified Duke criteria, which are
based on findings on physical examination, echocardiography, microbiologic studies, and …

Can the future of ID escape the inertial dogma of its past? The exemplars of shorter is better and oral is the new IV

K Davar, D Clark, RM Centor… - Open Forum …, 2023 - academic.oup.com
Like all fields of medicine, Infectious Diseases is rife with dogma that underpins much
clinical practice. In this study, we discuss 2 specific examples of historical practice that have …

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

M Pujol, JM Miró, E Shaw, JM Aguado… - Clinical Infectious …, 2021 - academic.oup.com
Background We aimed to determine whether daptomycin plus fosfomycin provides higher
treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus …